Cargando…

How do clinicians use implementation tools to apply breast cancer screening guidelines to practice?

BACKGROUND: Implementation tools (iTools) may enhance uptake of guidelines. However, little evidence exists on their use by primary care clinicians. This study explored which iTools clinicians used and how often; how satisfied clinicians were with the tools; whether tool use was associated with prac...

Descripción completa

Detalles Bibliográficos
Autores principales: Armson, Heather, Roder, Stefanie, Elmslie, Tom, Khan, Sobia, Straus, Sharon E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992659/
https://www.ncbi.nlm.nih.gov/pubmed/29879984
http://dx.doi.org/10.1186/s13012-018-0765-2
_version_ 1783330068756430848
author Armson, Heather
Roder, Stefanie
Elmslie, Tom
Khan, Sobia
Straus, Sharon E.
author_facet Armson, Heather
Roder, Stefanie
Elmslie, Tom
Khan, Sobia
Straus, Sharon E.
author_sort Armson, Heather
collection PubMed
description BACKGROUND: Implementation tools (iTools) may enhance uptake of guidelines. However, little evidence exists on their use by primary care clinicians. This study explored which iTools clinicians used and how often; how satisfied clinicians were with the tools; whether tool use was associated with practice changes; and identified mediators for practice change(s) related to breast cancer screening (BCS). METHODS: Canadian primary care providers who are members of the Practice-Based Small Group Learning Program (n = 1464) were invited to participate in this mixed methods study. An educational module was discussed in a small group learning context, and data collection included an on-line survey, practice reflection tools (PRTs), and interviews. The module included both the Canadian Task Force on Preventive Health Care revised guideline on BCS and iTools for clinician and/or patient use. After discussing the module and at 3 months, participants completed PRTs identifying their planned practice change(s) and documenting implementation outcome(s). Use of the iTools was explored via online survey and individual interviews. RESULTS: Seventy participants agreed to participate. Of these, 48 participated in the online survey, 43 completed PRTs and 14 were interviewed. Most survey participants (77%) reported using at least one of seven tools available for implementing BCS guideline. Of these (78%) reported using more than one tool. Almost all participants used tools for clinicians (92%) and 62% also used tools for patients. As more tools were used, more practice changes were reported on the survey and PRTs. Interviews provided additional findings. Once information from an iTool was internalized, there was no further need for the tool. Participants did not use tools (23%) due to disagreements with the BCS guideline, patients’ expectations, and/or experiences with diagnosis of breast cancer. CONCLUSION: This study found that clinicians use tools to implement practice changes related to BCS guideline. Tools developed for clinicians were used to understand and consolidate the recommendations before tools to be used with patients were employed to promote decision-making. Mediating factors that impacted tool use confirmed previous research. Finally, use of some iTools decreased over time because information was internalized. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13012-018-0765-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5992659
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59926592018-06-21 How do clinicians use implementation tools to apply breast cancer screening guidelines to practice? Armson, Heather Roder, Stefanie Elmslie, Tom Khan, Sobia Straus, Sharon E. Implement Sci Research BACKGROUND: Implementation tools (iTools) may enhance uptake of guidelines. However, little evidence exists on their use by primary care clinicians. This study explored which iTools clinicians used and how often; how satisfied clinicians were with the tools; whether tool use was associated with practice changes; and identified mediators for practice change(s) related to breast cancer screening (BCS). METHODS: Canadian primary care providers who are members of the Practice-Based Small Group Learning Program (n = 1464) were invited to participate in this mixed methods study. An educational module was discussed in a small group learning context, and data collection included an on-line survey, practice reflection tools (PRTs), and interviews. The module included both the Canadian Task Force on Preventive Health Care revised guideline on BCS and iTools for clinician and/or patient use. After discussing the module and at 3 months, participants completed PRTs identifying their planned practice change(s) and documenting implementation outcome(s). Use of the iTools was explored via online survey and individual interviews. RESULTS: Seventy participants agreed to participate. Of these, 48 participated in the online survey, 43 completed PRTs and 14 were interviewed. Most survey participants (77%) reported using at least one of seven tools available for implementing BCS guideline. Of these (78%) reported using more than one tool. Almost all participants used tools for clinicians (92%) and 62% also used tools for patients. As more tools were used, more practice changes were reported on the survey and PRTs. Interviews provided additional findings. Once information from an iTool was internalized, there was no further need for the tool. Participants did not use tools (23%) due to disagreements with the BCS guideline, patients’ expectations, and/or experiences with diagnosis of breast cancer. CONCLUSION: This study found that clinicians use tools to implement practice changes related to BCS guideline. Tools developed for clinicians were used to understand and consolidate the recommendations before tools to be used with patients were employed to promote decision-making. Mediating factors that impacted tool use confirmed previous research. Finally, use of some iTools decreased over time because information was internalized. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13012-018-0765-2) contains supplementary material, which is available to authorized users. BioMed Central 2018-06-07 /pmc/articles/PMC5992659/ /pubmed/29879984 http://dx.doi.org/10.1186/s13012-018-0765-2 Text en © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Armson, Heather
Roder, Stefanie
Elmslie, Tom
Khan, Sobia
Straus, Sharon E.
How do clinicians use implementation tools to apply breast cancer screening guidelines to practice?
title How do clinicians use implementation tools to apply breast cancer screening guidelines to practice?
title_full How do clinicians use implementation tools to apply breast cancer screening guidelines to practice?
title_fullStr How do clinicians use implementation tools to apply breast cancer screening guidelines to practice?
title_full_unstemmed How do clinicians use implementation tools to apply breast cancer screening guidelines to practice?
title_short How do clinicians use implementation tools to apply breast cancer screening guidelines to practice?
title_sort how do clinicians use implementation tools to apply breast cancer screening guidelines to practice?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992659/
https://www.ncbi.nlm.nih.gov/pubmed/29879984
http://dx.doi.org/10.1186/s13012-018-0765-2
work_keys_str_mv AT armsonheather howdocliniciansuseimplementationtoolstoapplybreastcancerscreeningguidelinestopractice
AT roderstefanie howdocliniciansuseimplementationtoolstoapplybreastcancerscreeningguidelinestopractice
AT elmslietom howdocliniciansuseimplementationtoolstoapplybreastcancerscreeningguidelinestopractice
AT khansobia howdocliniciansuseimplementationtoolstoapplybreastcancerscreeningguidelinestopractice
AT straussharone howdocliniciansuseimplementationtoolstoapplybreastcancerscreeningguidelinestopractice